Minimally Invasive/Focused Parathyroidectomy in Patients With Negative Sestamibi Scan Results | Endocrine Surgery | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.187.155. Please contact the publisher to request reinstatement.
1.
Felger EA, Kandil E. Primary hyperparathyroidism.  Otolaryngol Clin North Am. 2010;43(2):417-432, x20510724PubMedGoogle ScholarCrossref
2.
Sackett WR, Barraclough B, Reeve TS, Delbridge LW. Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy.  Arch Surg. 2002;137(9):1055-105912215160PubMedGoogle ScholarCrossref
3.
Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism.  Ann Surg. 2002;235(5):665-67211981212PubMedGoogle ScholarCrossref
4.
Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial.  Ann Surg. 2002;236(5):543-55112409657PubMedGoogle ScholarCrossref
5.
Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism.  Ann Surg. 2000;231(5):732-74210767795PubMedGoogle ScholarCrossref
6.
Irvin GL III, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome.  World J Surg. 2004;28(12):1287-129215517474PubMedGoogle ScholarCrossref
7.
Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL III. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?  Surgery. 2003;134(6):973-98114668730PubMedGoogle ScholarCrossref
8.
Kandil E, Alabbas HH, Bansal A, Islam T, Tufaro AP, Tufano RP. Intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma.  Arch Otolaryngol Head Neck Surg. 2009;135(12):1206-120820026817PubMedGoogle ScholarCrossref
9.
Lavely WC, Goetze S, Friedman KP,  et al.  Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.  J Nucl Med. 2007;48(7):1084-108917574983PubMedGoogle ScholarCrossref
10.
Ahmad R, Hammond JM. Primary, secondary, and tertiary hyperparathyroidism.  Otolaryngol Clin North Am. 2004;37(4):701-713, vii-viii15262510PubMedGoogle ScholarCrossref
11.
Eslamy HK, Ziessman HA. Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99m Tc sestamibi SPECT and SPECT/CT.  Radiographics. 2008;28(5):1461-147618794320PubMedGoogle ScholarCrossref
12.
Caixàs A, Bernà L, Hernández A,  et al.  Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidism.  Surgery. 1997;121(5):535-5419142152PubMedGoogle ScholarCrossref
13.
Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003.  Otolaryngol Head Neck Surg. 2005;132(3):359-37215746845PubMedGoogle ScholarCrossref
14.
Lew JI, Irvin GL III. Focused parathyroidectomy guided by intra-operative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome.  Surgery. 2009;146(6):1021-102719879612PubMedGoogle ScholarCrossref
15.
Kandil E, Carson KA, Tufaro AP,  et al.  Role of preoperative intact parathyroid hormone levels in predicting the likelihood of multiglandular disease in primary hyperparathyroidism.  Head Neck. 2010;33(4):543-54620872837PubMedGoogle ScholarCrossref
16.
Allendorf J, DiGorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism.  World J Surg. 2007;31(11):2075-208017768656PubMedGoogle ScholarCrossref
17.
Chan RK, Ruan DT, Gawande AA, Moore FD Jr. Surgery for hyperparathyrodism in image-negative patients.  Arch Surg. 2008;143(4):335-33718427019PubMedGoogle ScholarCrossref
18.
Solorzano CC, Lee TM, Ramirez MC, Carneiro DM, Irvin GL. Surgeon-performed ultrasound improves localization of abnormal parathyroid glands.  Am Surg. 2005;71(7):557-56316089118PubMedGoogle Scholar
19.
Casas AT, Burke GJ, Sathyanarayana , Mansberger AR Jr, Wei JP. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.  Am J Surg. 1993;166:369-3738214295PubMedGoogle ScholarCrossref
20.
Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy.  Clin Endocrinol (Oxf). 2002;57(2):241-24912153604PubMedGoogle ScholarCrossref
21.
Lal A, Chen H. The negative sestamibi scan: is a minimally invasive parathyroidectomy still possible?  Ann Surg Oncol. 2007;14(8):2363-236617522941PubMedGoogle ScholarCrossref
22.
Chiu B, Sturgeon C, Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success? a study of 352 consecutive patients.  Arch Surg. 2006;141(5):483-48816702520PubMedGoogle ScholarCrossref
23.
Levy JM, Kandil E, Yau LC, Cuda JD, Sheth SN, Tufano RP. Can ultrasound be used as the primary screening modality for the localization of parathyroid disease prior to surgery for primary hyperparathyroidism? a review of 440 cases.  ORL J Otorhinolaryngol Relat Spec. 2011;73(2):116-12021389743PubMedGoogle ScholarCrossref
Original Article
Mar 2012

Minimally Invasive/Focused Parathyroidectomy in Patients With Negative Sestamibi Scan Results

Author Affiliations

Author Affiliations: Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana (Drs Kandil, Malazai, and Alrasheedi); and Department of Otolaryngology–Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Tufano).

Arch Otolaryngol Head Neck Surg. 2012;138(3):223-225. doi:10.1001/archoto.2011.1419
Abstract

Objective To examine the feasibility of minimally invasive/focused parathyroidectomy in patients with primary hyperparathyroidism and negative results on preoperative sestamibi scanning.

Design Retrospective review.

Setting Hospital.

Patients A total of 452 patients with primary hyperparathyroidism underwent parathyroidectomy between January 2005 and December 2009.

Main Outcome Measures Preoperative sestamibi scans were reviewed, and their influence on the surgical outcome was examined. Records of the intraoperative and postoperative findings were also reviewed.

Results Seventy-seven patients (17.0%) were found to have negative results on preoperative sestamibi scans, and these patients formed our cohort study group. In this group, neck ultrasonography performed as an adjunct was able to preoperatively localize an area that was suggestive of a single adenoma in 61 patients (79.2%), 53 of whom were confirmed to have a single adenoma intraoperatively (sensitivity, 80.3%; specificity, 27.3%; positive predictive value, 86.9%; and negative predictive value, 18.8%). In total, 66 of 77 patients (85.7%) were confirmed to have a single adenoma at the time of surgery.

Conclusions Negative results on sestamibi scans should not be used as exclusion criteria for minimally invasive/focused parathyroidectomy in patients with primary hyperparathyroidism. In our study, 66 patients with negative results on preoperative scans were found to have a single adenoma and were surgically cured by minimally invasive/focused parathyroidectomy.

×